glp 1 for weight loss brand name GLP-1 Therapy Medication Clinically backed oral GLP Innovative Primary Care Helps Patients

GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK/NF-kappaB pathway in neuropathic pain mice

A 2022 randomized trial of exenatide did not meet its primary endpoint for reducing heavy drinking days in the overall population, though exploratory analyses suggested potential benefits in participants with obesity

Led by Maureen Gerry, a certified health coach with extensive experience in transforming lives through diet and exercise, this program offers a supportive and informative environment

Koya Y, Shibata M, Senju M, Honma Y, Hiura M, Ishii M, Matsumoto S, Harada M

BPC-157 clinical trial registry search (no active US Phase 1-3 trials)